The bottom line.
Page/Link:
Page URL:
HTML link:
Citations:
The Bottom Line
Data from recent industry financial reports. Dollar amounts in millions.
Company Period Ended Sales Chg.
ACLARA BioSciences 2Q 30-Jun $ 0.8 -10.6%
Axon Instruments 1H 30-Jun $ 18.5 43.4%
Bioanalytical Systems 3Q 30-Jun $ 6.4 17.4%
CRS Robotics 2Q 30-Jun $ 7.2 93.0%
Harvard Bioscience 2Q 30-Jun $ 9.7 31.4%
IGEN International 1Q 30-Jun $ 8.3 9.0%
InVision Technologies 2Q 1-Jul $ 17.4 2.5%
Ionics 2Q 30-Jun $ 113.7 10.6%
MTS Corp. 3Q 30-Jun $ 98.6 3.8%
Nanometrics 2Q 30-Jun $ 14.8 -11.4%
Orchid BioSciences, Inc. 2Q 30-Jun $ 6.7 46.2%
Osmonics 2Q 30-Jun $ 51.7 3.2%
Pyrosequencing AB 2Q 30-Jun $ 13.6 148.4%
Rheometric Scientific 1Q 31-Mar $ 7.6 15.5%
Rheometric Scientific 2Q 30-Jun $ 7.4 -5.3%
Tripos, Inc. 2Q 30-Jun $ 10.6 93.6%
Zygo 4Q 30-Jun $ 37.9 58.7%
Zygo FYE 30-Jun $ 133.3 52.7%
Company Op. Prof. Chg. Net Prof. Chg.
ACLARA BioSciences $ (5.2) NM $ (3.2) NM
Axon Instruments N/A N/A $ 1.0 11.1%
Bioanalytical Systems $ (0.9) NM $ (0.5) NM
CRS Robotics $ 0.3 111.0% $ 0.0 -79.3%
Harvard Bioscience $ 1.2 1.3% $ 1.0 96.2%
IGEN International $ (6.4) NM $ (11.9) NM
InVision Technologies $ (0.3) NM $ (0.1) NM
Ionics $ 5.8 -15.0% $ 4.2 -1.1%
MTS Corp. $ 9.0 38.1% $ 4.4 20.3%
Nanometrics $ 1.8 -46.8% $ 1.5 -47.9%
Orchid BioSciences, Inc. $ (15.1) NM $ (14.3) NM
Osmonics $ 2.6 -3.2% $ 1.2 -37.2%
Pyrosequencing AB $ (4.3) NM $ (3.6) NM
Rheometric Scientific $ 0.2 93.3% $ (0.4) NM
Rheometric Scientific $ (0.0) NM $ (0.5) NM
Tripos, Inc. $ 1.1 NM $ 2.3 NM
Zygo $ 4.5 NM $ 4.7 NM
Zygo $ 13.6 NM $ 10.7 NM
NA = not available
NM = not meaningful
COPYRIGHT 2001 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.
Printer friendly
Cite/link
Email
Feedback